SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Spherix Incorporated (not Dominari Holdings Inc.) with a report date of January 1, 2013, and signed on January 30, 2013. The filing discloses the entry into a Material Definitive Agreement and a Material Modification to the Rights of Security Holders.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on corporate governance and capital structure changes regarding a poison pill defense mechanism.
Material Changes
Effective January 1, 2013, the Board of Directors authorized a stock rights plan (poison pill) to protect stockholders from coercive or unfair takeover tactics. Key changes include:
- Issuance of Rights: One preferred share purchase right (a "Right") was issued for each outstanding share of common stock.
- Trigger Threshold: The plan is triggered if any person or group acquires 10% or more of the outstanding common shares without Board approval.
- Expiration: The Rights expire on December 31, 2017, unless earlier redeemed or exchanged.
Guidance, Outlook, and Management Commentary
Management states the Rights Agreement is designed to render more difficult or discourage mergers, tender offers, or business combinations not approved by the Board. The plan should not interfere with transactions approved by the Board, as the Board retains the ability to redeem the Rights.
Key Terms of the Rights Plan:
- Purchase Price: Each Right entitles the holder to purchase one one-hundredth of a share of Series A Participating Preferred Stock at a price of $7.46.
- Flip-In Provision: If an "Acquiring Person" acquires 10% or more, holders (excluding the Acquiring Person) may purchase common shares (or equivalents) with a value equal to two times the exercise price (effectively a 50% discount).
- Flip-Over Provision: If the Company is acquired in a merger after an Acquiring Person emerges, Rights may be exercised for shares of the acquiring company at a 50% discount.
- Redemption: The Board may redeem the Rights at $0.001 per Right at any time prior to the emergence of an Acquiring Person.
- Preferred Stock Features: The underlying Preferred Shares carry significant voting power (100 votes per share) and preferential dividend/liquidation rights (100 times the common share amount).
Investor Verification Checklist
- Verify the exact number of outstanding common shares as of the January 1, 2013 Record Date to calculate the total number of Rights issued.
- Review the attached Exhibit 4.1 (Rights Agreement) for specific adjustment formulas regarding stock splits, dividends, or recapitalizations.
- Confirm the current market price of Spherix common stock to assess the immediate dilution impact if the 10% trigger were activated.
- Check for any subsequent filings indicating the redemption of the Rights or a change in the 10% ownership threshold.